Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v6-FR
Language English French
Date Updated 2019-09-06 2017-03-13
Drug Identification Number 02248361 02248361
Brand name VIVAXIM VIVAXIM
Common or Proper name Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED
Strength(s) 25MCG 160UNIT 25MCG 160UNIT
Dosage form(s) SOLUTION SUSPENSION SOLUTION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL 1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL
ATC code J07CA J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2016-11-16 2016-11-16
Actual start date 2016-11-16 2016-11-16
Estimated end date 2019-01-31 2018-03-01
Actual end date 2019-09-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments The shortage has been resolved. Supply disruptions are anticipated in the private market.
Health Canada comments